Red cell preparations
The components listed in points 1.1 to 1.8 may be further processed within blood establishments and must be labelled accordingly
1.1 | Red cells
1.2 | Red cells, buffy coat removed
1.3 | Red cells, leucocyte-depleted
1.4 | Red cells, in additive solution
1.5 | Red cells, buffy coat removed, in additive solution
1.6 | Red cells, leucocyte-depleted, in additive solution
1.7 | Red cells, apheresis
1.8 | Whole blood
Platelet preparations
The components listed in points 2.1 to 2.6 may be further processed within blood establishments and must be labelled accordingly
2.1 | Platelets, apheresis
2.2 | Platelets, apheresis, leucocyte-depleted
2.3 | Platelets, recovered, pooled
2.4 | Platelets, recovered, pooled, leucocyte-depleted
2.5 | Platelets, recovered, single unit
2.6 | Platelets, recovered, single unit, leucocyte-depleted
Plasma preparations
The components listed in 3.1 to 3.3 may be further processed within blood establishments and must be labelled accordingly.
3.1 | Fresh-frozen plasma
3.2 | Fresh-frozen plasma, cryoprecipitate-depleted
3.3 | Cryoprecipitate
| Granulocytes, apheresis
New components
Quality and safety requirements for new blood components must be regulated by the competent national authority. Such new components must be notified to the European Commission with a view to Community action
2.1.
Blood and blood components must comply with the following technical quality measurements and meet the acceptable results.
2.2.
Appropriate bacteriological control of the collection and manufacturing process must be performed.
2.3.
Member States must take all necessary measures to ensure that all imports of blood and blood components from third countries, including those used as starting material/raw material for the manufacture of medicinal products derived from human blood or human plasma, shall meet equivalent standards of quality and safety to the ones laid down in this Directive.
2.4.
For autologous donations, the measures marked with an asterisk (*) are recommendations only.
Component |
Quality measurements required
The required frequency of sampling for all measurements shall be determined using statistical process control
Acceptable results for quality measurements
Red cells | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 45 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, buffy coat removed | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 43 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 40 g per unit
Leucocyte content | Less than 1 × 106 per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 45 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, buffy coat removed, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 43 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, leucocyte-depleted, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 40 g per unit
Leucocyte content | Less than 1 × 106 per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Red cells, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*) | Not less than 40 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Whole blood | Volume |
Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
450 ml +/- 50ml
For paediatric autologous whole blood collections — not to exceed 10,5 ml per kg body weight
Haemoglobin (*) | Not less than 45 g per unit
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life
Platelets, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Platelets, apheresis, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content | Less than 1 × 106 per unit
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Platelets, recovered, pooled | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content |
Less than 0,2 × 109 per single unit (platelet-rich plasma method)
Less than 0,05 × 109 per single unit (buffy coat method)
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Platelets, recovered, pooled, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content | Less than 1 × 106 per pool
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Platelets, recovered, single unit | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content |
Less than 0,2 × 109 per single unit (platelet-rich plasma method)
Less than 0,05 × 109 per single unit (buffy coat method)
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Platelets, recovered, single unit, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions
Leukocyte content | Less than 1 × 106 per unit
pH | Minimum 6,4 corrected for 22 °C, at the end of the shelf life
Plasma, fresh-frozen | Volume | Stated volume +/- 10 %
Factor VIIIc (*) | Average (after freezing and thawing): 70 % or more of the value of the freshly collected plasma unit
Total protein (*) | Not less than 50 g/l
Residual cellular content (*) |
Red cells: less than 6,0 × 109/l
Leucocytes: less than 0, 1 × 109/l
Platelets: less than 50 × 109/l
Plasma, fresh-frozen, cryoprecipitate-depleted | Volume | Stated volume: +/- 10 %
Residual cellular content (*) |
Red cells: less than 6,0 × 109/l
Leucocytes: less than 0,1 × 109/l
Platelets: less than 50 × 109/l
Cryoprecipitate | Fibrinogen content (*) | Greater than or equal to 140 mg per unit
Factor VIIIc content (*) | Greater than or equal to 70 international units per unit
Granulocytes, apheresis | Volume | Less than 500 ml
Granulocyte content | Greater than 1 × 1010 granulocytes per unit